[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Nucleic Acid Isolation and Purification Market: Focus on Product, End User, Region/Country Data and Competitive Landscape - Analysis and Forecast, 2020-2029

March 2020 | 388 pages | ID: G094DF43C91EEN
BIS Research Inc.

US$ 8,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Key Questions Answered in this Report:
  • What are the major market drivers, challenges, and opportunities in the global nucleic acid isolation and purification market?
  • What are the key development strategies which are being implemented by major players in order to sustain in the competitive market?
  • How each segment of the market is expected to grow during the forecast period from 2020 to 2029 based on
    • product type: instrument and consumables (kits and reagents)
    • end User: academic research institutes, pharmaceutical and biotechnology companies, applied testing, contract research organizations, and clinical diagnostic centers
    • region, North America, EMEA, Asia-Pacific, and Latin America
  • Which are the leading players with significant offerings to the global nucleic acid isolation and purification market? What is the expected market dominance for each of these leading players?
  • Which companies are anticipated to be highly disruptive in the future and why?
  • What are the challenges in the nucleic acid isolation and purification market?
Global Nucleic Acid Isolation and Purification Market Forecast, 2020-2029

The nucleic acid isolation and purification industry analysis by BIS Research projects the market to grow at a significant CAGR of 5.98% during the forecast period, 2020-2029. The nucleic acid isolation and purification market generated $2,273.9 million revenue in 2020, in terms of value. The nucleic acid isolation and purification market growth has been primarily attributed to the major drivers in this market, such as growing number of genetic tests, increasing demand for reliable next-generation sequencing (NGS) results, rise in the prevalence of infectious diseases, increasing research funding in the field of molecular biology, and increase in awareness and acceptance of personalized medicine on a global level. However, genomic data protection, high cost of automated instruments, and rigid regulatory standards are some of the factors expected to retrain the market growth.

Expert Quote

“As molecular diagnostic testing moves into the clinical laboratory environment, products used to collect and process samples will need to be standardized”

Scope of the Market Intelligence on Nucleic Acid Isolation and Purification Market

The nucleic acid isolation and purification research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers. In addition, the study also includes exhaustive information on the drivers, restraints opportunities, perception of the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global nucleic acid isolation and purification market.

Market Segmentation

The nucleic acid isolation and purification market (on the basis of product type) is segmented into instruments and consumables (kits and reagents).

The kits segment (on the basis of technology) has been classified into magnetic particle technology, silica technology, and other technologies. The other technologies have been broadly bifurcated into anion-exchange technology, lysis, precipitation-based chemistries, organic extraction, fluorescence, and other kits technologies.

Further, the instruments (on the basis of technology) has been classified into automated spin-column based and bead-based. The bead-based technology has been further bifurcated into magnetic bead-based and automated liquid handling.

The nucleic acid isolation and purification market (on the basis of applications) is segmented into PCR, qPCR, NGS, cloning, microarray, blotting techniques, and other applications.

The nucleic acid isolation and purification market (on the basis of end-user) is segmented into academic research institutes, pharmaceutical and biotechnology companies, applied testing, biobanks, contract research organizations, hospital research laboratories, and clinical diagnostic centers.

The nucleic acid isolation and purification market (on the basis of region) is segmented into North America, EMEA, Asia-Pacific, and Latin America.

Key Companies in the Nucleic Acid Isolation and Purification Market

The key manufacturers who have been contributing significantly to the nucleic acid isolation and purification market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F.Hoffmann-La Roche AG, Illumina, Inc., General Electric Company (GE), New England Biolabs, Inc., Promega Corporation, Merck KGaA, Takara Bio Inc., QIAGEN N.N., Thermo Fisher Scientific Inc., and Promega Corporation, among others.
1 PRODUCT DEFINITION

1.1 Inclusion and Exclusion

2 RESEARCH SCOPE

2.1 Scope of the Study
2.2 Key Questions Answered in the Report

3 RESEARCH METHODOLOGY

3.1 Global Nucleic Acid Isolation and Purification Market: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model

4 MARKET OVERVIEW

4.1 Definitions
  4.1.1 Product Definition
  4.1.2 Definition by Products
    4.1.2.1 Instruments
    4.1.2.2 Column-Based Instruments
    4.1.2.3 Bead-Based Instruments
    4.1.2.4 Low-Throughput Instruments
    4.1.2.5 Medium-Throughput Instruments
    4.1.2.6 High-Throughput Instruments
    4.1.2.7 Kits
    4.1.2.8 Reagents
4.2 Nucleic Acid Isolation and Purification Automation Applications
  4.2.1 Genomic/Plasmid DNA Extraction
  4.2.2 Cell-Free DNA (cfDNA) Extraction
  4.2.3 Viral RNA Extraction
  4.2.4 Cell-Free RNA Extraction
4.3 Market Size and Growth Potential, $Million, 2019-2029
  4.3.1 North America
  4.3.2 Europe, Middle East & Africa (EMEA)
  4.3.3 Asia-Pacific (APAC)
  4.3.4 Latin America

5 MARKET DYNAMICS

5.1 Market Drivers
  5.1.1 Growing Number of Genetic Tests
  5.1.2 Increasing Demand for Reliable Next-Generation Sequencing (NGS) Results
  5.1.3 Rise in the Prevalence of Infectious Disease
  5.1.4 Rise in the Field of Microbial Sequencing
  5.1.5 Increasing Research Funding in the Field of Molecular Biology
  5.1.6 Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
5.2 Market Restraints
  5.2.1 Genomic Data Protection
  5.2.2 High Cost of Automated Instruments
  5.2.3 Rigid Regulatory Standards
5.3 Market Opportunities
  5.3.1 Evolution of Biobanking in Healthcare
  5.3.2 Capitalizing on the High Prevalence of Genetic Disorders
  5.3.3 Growth in Emerging Nations

6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INDUSTRY INSIGHTS

6.1 Key Developments
  6.1.1 Product Launches and Enhancements
  6.1.2 Collaborations and Agreements
  6.1.3 Acquisitions
  6.1.4 Business Expansions
6.2 Industry Trends
  6.2.1 Emergence of Advanced Stabilization Products
  6.2.2 Regulated vs. Multimodal Analysis
  6.2.3 Novel Targets for Isolation and Purification
  6.2.4 Exploring New Applications
  6.2.5 Other Key Trends

7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: END USER AND PRICING ANALYSIS

7.1 Satisfaction Level of Different Instruments (by Brand)
7.2 Pricing Analysis of Preferred Instruments
7.3 Pricing Analysis - Accessories and Components
7.4 Pricing Analysis – Consumables

8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (BY PRODUCT), $MILLION, 2019-2029

8.1 Introduction
8.2 Consumables
  8.2.1 Kits
  8.2.2 Reagents
8.3 Instruments

9 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, $MILLION, 2019-2029

9.1 By Workflow
  9.1.1 Sample Isolation/Extraction/Purification
  9.1.2 DNA/RNA Clean-Up and Concentration
  9.1.3 DNA and RNA Quantification
9.2 By Analyte
  9.2.1 DNA
  9.2.2 RNA

10 DNA ISOLATION AND PURIFICATION KITS MARKET, (BY SOURCE TYPE) $MILLION, 2019-2029

10.1 Cell-Free
  10.1.1 By Sample
    10.1.1.1 Blood
    10.1.1.2 Serum/Plasma
    10.1.1.3 Other Sources
  10.1.2 By Application
    10.1.2.1 Parental and Hereditary Testing
    10.1.2.2 Tumor Testing
    10.1.2.3 Transplantation
10.2 Genomic
  10.2.1 Blood
  10.2.2 Body Fluids
  10.2.3 Buccal
  10.2.4 Cell/Cultured Cell
  10.2.5 FFPE
  10.2.6 Forensic
  10.2.7 Plant
  10.2.8 Saliva/Swab
  10.2.9 Serum/Plasma
  10.2.10 Tissue
  10.2.11 Stool, Urine, and Other Samples
10.3 Microbe
  10.3.1 Bacterial
  10.3.2 Fungus
  10.3.3 Yeast
  10.3.4 Other Sources
10.4 Plasmid
  10.4.1 GigaPrep
  10.4.2 MaxiPrep
  10.4.3 MegaPrep
  10.4.4 MidiPrep
  10.4.5 MiniPrep
10.5 Viral

11 RNA ISOLATION AND PURIFICATION KITS MARKET (BY SOURCE TYPE) $MILLION, 2019-2029

11.1 Genomic RNA
  11.1.1 Blood
  11.1.2 Body Fluids
  11.1.3 Cell/Cultured Cell
  11.1.4 FFPE
  11.1.5 Plant
  11.1.6 Saliva/Swab
  11.1.7 Serum/Plasma
  11.1.8 Tissue
  11.1.9 Urine
  11.1.10 Others
11.2 Microbial RNA
  11.2.1 Bacteria
  11.2.2 Yeast
  11.2.3 Fungus
  11.2.4 Others
11.3 Viral RNA
11.4 Cell-Free RNA
  11.4.1 Serum/Plasma
  11.4.2 Others

12 NUCLEIC ACID ISOLATION AND PURIFICATION CONSUMABLES MARKET (BY TECHNOLOGY), $MILLION, 2019-2029

12.1 Silica-Based
12.2 Magnetic Particle Technology
12.3 Other Technologies

13 NUCLEIC ACID ISOLATION AND PURIFICATION CONSUMABLES MARKET (BY DOWNSTREAM APPLICATIONS), $MILLION, 2019-2029

13.1 PCR
13.2 qPCR
13.3 NGS
13.4 Cloning
13.5 Microarray
13.6 Blotting Techniques
13.7 Other Applications

14 NUCLEIC ACID ISOLATION AND PURIFICATION CONSUMABLES MARKET (BY END USER), $MILLION, 2019-2029

14.1 Introduction
14.2 Academic Research Institutes and Laboratories
14.3 Pharmaceutical and Biotechnology Companies
14.4 Contract Research Organizations
14.5 Applied Testing
14.6 Clinical Diagnostic Centers

15 NUCLEIC ACID ISOLATION AND PURIFICATION CONSUMABLES MARKET (BY REGION)

15.1 North America
  15.1.1 U.S.
  15.1.2 Canada
15.2 Europe, Middle East & Africa (EMEA)
15.3 Latin America (LATAM)
15.4 Asia-Pacific
  15.4.1 China
  15.4.2 Japan
  15.4.3 Rest-of-APAC

16 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENT MARKET

16.1 Introduction
16.2 Nucleic Acid Isolation and Purification Instrument Market (by Workflow)
  16.2.1 Isolation/Extraction/Purification
  16.2.2 Quality Control/Quantification
16.3 Nucleic Acid Isolation and Purification Instrument Market (by Technology)
  16.3.1 Automated Spin Column-Based Instruments
  16.3.2 Magnetic Bead-based Instruments
  16.3.3 Automated Liquid Handling Instruments
16.4 Nucleic Acid Isolation and Purification Instrument Market (by Throughput)
  16.4.1 Low Throughput Instruments
  16.4.2 Medium Throughput Instruments
  16.4.3 High Throughput Instruments
16.5 Quality Control/Quantification Instruments (by Technology)
  16.5.1 Spectrophotometer
  16.5.2 Fluorometers
  16.5.3 Others
16.6 Nucleic Acid Isolation and Purification Instrument Market (by End User)
  16.6.1 Academic Research Institutes
  16.6.2 Pharmaceutical and Biotechnology Companies
  16.6.3 Clinical Diagnostic Centers
  16.6.4 Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
  16.6.5 Contract Research Organizations
16.7 Nucleic Acid Isolation and Purification Instrument Market (by Region)
  16.7.1 North America
    16.7.1.1 U.S.
    16.7.1.2 Canada
  16.7.2 Europe, Middle East and Africa
  16.7.3 Asia-Pacific
    16.7.3.1 China
    16.7.3.2 Japan
    16.7.3.3 Rest-of-APAC
  16.7.4 Latin America

17 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET COMPETITIVE LANDSCAPE

17.1 Market Share Analysis (Regional and Global)
  17.1.1 Global
  17.1.2 North America
  17.1.3 EMEA
17.2 Growth Share Matrix by End User
17.3 Growth Share Matrix by Region
17.4 Growth Share Matrix by Products

18 STRATEGIC RECOMMENDATIONS

18.1 Key Takeaways
18.2 Gap Analysis
18.3 Business Expansion Opportunity Mapping
  18.3.1 By Product
  18.3.2 By Region
18.4 Investment Opportunities
18.5 SWOT Analysis
18.6 Propitious Strategies to Succeed in Nucleic Acid Isolation and Purification Market

19 COMPANY PROFILES

19.1 Overview
19.2 Agilent Technologies, Inc.
  19.2.1 Company Overview
  19.2.2 Role of Agilent Technologies, Inc. in the Global Nucleic Acid Isolation and Purification Market
  19.2.3 Financials
  19.2.4 Key Insights About Financial Health of the Company
  19.2.5 SWOT Analysis
19.3 Analytik Jena AG
  19.3.1 Company Overview
  19.3.2 Role of Analytik Jena AG in the Global Nucleic Acid Isolation and Purification Market
  19.3.3 SWOT Analysis
19.4 Bio-Rad Laboratories, Inc.
  19.4.1 Company Overview
  19.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Nucleic Acid Isolation and Purification Market
  19.4.3 Financials
  19.4.4 Key Insights About Financial Health of the Company
  19.4.5 SWOT Analysis
19.5 Exact Sciences Corporation
  19.5.1 Company Overview
  19.5.2 Role of Exact Sciences Corporation in the Global Nucleic Acid Isolation and Purification Market
  19.5.3 Financials
  19.5.4 Key Insights about Financial Health of the Company
  19.5.5 SWOT Analysis
19.6 F. Hoffmann-La Roche AG
  19.6.1 Company Overview
  19.6.2 Role of F. Hoffmann-La Roche AG in the Global Nucleic Acid Isolation and Purification Market
  19.6.3 Financials
  19.6.4 Key Insights About Financial Health of the Company
  19.6.5 SWOT Analysis
19.7 General Electric Company (GE)
  19.7.1 Company Overview
  19.7.2 Role of GE in the Global Nucleic Acid Isolation and Purification Market
  19.7.3 Financials
  19.7.4 Key Insights about Financial Health of the Company
  19.7.5 SWOT Analysis
19.8 Illumina, Inc.
  19.8.1 Company Overview
  19.8.2 Role of Illumina, Inc. in the Global Nucleic Acid Isolation and Purification Market
  19.8.3 Financials
  19.8.4 Key Insights About Financial Health of the Company
  19.8.5 SWOT Analysis
19.9 Merck KGaA
  19.9.1 Company Overview
  19.9.2 Role of Merck KGaA in the Global Nucleic Acid Isolation and Purification Market
  19.9.3 Financials
  19.9.4 Key Insights About Financial Health of the Company
  19.9.5 SWOT Analysis
19.10 Meridian Bioscience, Inc.
  19.10.1 Company Overview
  19.10.2 Role of Meridian Bioscience in the Global Nucleic Acid Isolation and Purification Market
  19.10.3 Financials
  19.10.4 Key Insights about Financial Health of the Company
  19.10.5 SWOT Analysis
19.11 Macherey-Nagel GmbH & Co KG
  19.11.1 Company Overview
  19.11.2 Role of Macherey-Nagel GmbH & Co KG in the Global Nucleic Acid Isolation and Purification Market
  19.11.3 SWOT Analysis
19.12 New England Biolabs, Inc
  19.12.1 Company Overview
  19.12.2 Role of New England Biolabs, Inc. in the Global Nucleic Acid Isolation and Purification Market
  19.12.3 SWOT Analysis
19.13 Norgen Biotek Corp.
  19.13.1 Company Overview
  19.13.2 Role of Norgen Biotek Corp. in the Global Nucleic Acid Isolation and Purification Market
  19.13.3 SWOT Analysis
19.14 Omega Bio-Tek
  19.14.1 Company Overview
  19.14.2 Role of Omega Bio-Tek in the Global Nucleic Acid Isolation and Purification Market
  19.14.3 SWOT Analysis
19.15 Orasure Technologies, Inc.
  19.15.1 Company Overview
  19.15.2 Role of Orasure Technologies in the Global Nucleic Acid Isolation and Purification Market
  19.15.3 Financials
  19.15.4 Key Insights about Financial Health of the Company
  19.15.5 SWOT Analysis
19.16 PerkinElmer, Inc.
  19.16.1 Company Overview
  19.16.2 Role of PerkinElmer, Inc. in the Nucleic Acid Isolation and Purification Market
  19.16.3 Financials
  19.16.4 SWOT Analysis
19.17 Promega Corporation
  19.17.1 Company Overview
  19.17.2 Role of Promega Corporation in the Global Nucleic Acid Isolation and Purification Market
  19.17.3 SWOT Analysis
19.18 QIAGEN N.V.
  19.18.1 Company Overview
  19.18.2 Role of QIAGEN N.V. plc in the Global Nucleic Acid Isolation and Purification Market
  19.18.3 Financials
  19.18.4 Key Insights About Financial Health of the Company
  19.18.5 SWOT Analysis
19.19 Sage Science, Inc.
  19.19.1 Company Overview
  19.19.2 Role of Sage Science, Inc. in the Global Nucleic Acid Isolation and Purification Market
  19.19.3 SWOT Analysis
19.20 Tecan Group
  19.20.1 Company Overview
  19.20.2 Role of Tecan Group in the Global Nucleic Acid Isolation and Purification Market
  19.20.3 Financials
  19.20.4 Key Insights about Financial Health of the Company
  19.20.5 SWOT Analysis
19.21 ThermoFisher Scientific Inc.
  19.21.1 Company Overview
  19.21.2 Role of Thermo Fisher Scientific in the Global Nucleic Acid Isolation and Purification Market
  19.21.3 Financials
  19.21.4 Key Insights About Financial Health of the Company
  19.21.5 SWOT Analysis
19.22 Zymo Research
  19.22.1 Company Overview
  19.22.2 Role of Zymo Research in the Global Nucleic Acid Isolation and Purification Market
  19.22.3 SWOT Analysis

LIST OF TABLES

Table 5.1: Other Key Research Funding for Nucleic Acid Extraction
Table 6.1: Commercially Available CTC Isolation Technologies
Table 6.2: Key Market Players Offering UltraPure Extraction Kits
Table 7.1: Key Automated DNA Extraction Systems Price and Material Cost per Sample
Table 7.2: Pricing of Market Available Consumables
Table 12.1: Other Technologies Consumables Market, $Million, 2019-2029
Table 14.1: Academic Research Institutes and Laboratories Consumables Market (by Analyte), $Million, 2019-2029
Table 14.2: Pharmaceutical and Biotechnology Companies Consumables Market (by Analyte), $Million, 2019-2029
Table 14.3: Contract Research Organizations Consumables Market (by Analyte), $Million, 2019-2029
Table 14.4: Applied Testing Consumables Market, (by Analyte) $Million, 2019-2029
Table 14.5: Contract Research Organizations Consumables Market (by Analyte), $Million, 2019-2029
Table 15.1: Global Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2019-2029
Table 15.2: Global DNA Isolation and Purification Kits Market (by Region), $Million, 2019-2029
Table 15.3: Global RNA Isolation and Purification Kits Market (by Region), $Million, 2019-2029
Table 15.4: Global Nucleic Acid Isolation and Purification Reagents Market (by Region), $Million, 2019-2029
Table 15.5: North America Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2019-2029
Table 15.6: North America DNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
Table 15.7: North America RNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
Table 15.8: EMEA Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2019-2029
Table 15.9: EMEA Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2019-2029
Table 15.10: EMEA DNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
Table 15.11: EMEA RNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
Table 15.12: LATAM Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2019-2029
Table 15.13: LATAM Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2019-2029
Table 15.14: LATAM DNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
Table 15.15: LATAM RNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
Table 15.16: APAC Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2019-2029
Table 15.17: APAC Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2019-2029
Table 15.18: APAC DNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
Table 15.19: APAC RNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
Table 16.1: Key Isolation/Extraction/Purification Systems for Nucleic Acids
Table 16.2: Key Quality Control/Quantification Systems for Nucleic Acids
Table 16.3: Key Column-Based Systems for Nucleic Acid Extraction
Table 16.4: Key Magnetic Bead-Based Systems for Nucleic Acid Extraction
Table 16.5: Key Low Throughput Systems for Nucleic Acid Extraction
Table 16.6: Key Medium Throughput Systems for Nucleic Acid Extraction
Table 16.7: Key High Throughput Systems for Nucleic Acid Extraction
Table 16.8: Key Spectrophotometer Systems for Quality Control/Quantification
Table 16.9: Key Fluorometers Systems for Quality Control/Quantification
Table 16.10: Key Other Systems for Quality Control/Quantification
Table 16.11: Collaborations in Genetics and Genomics Research in Africa, by Funder
Table 18.1: Major Issues in Research Laboratories in the Asia-Pacific Region
Table 18.2: Funding Scenario in the Competitive Genomic Landscape

LIST OF FIGURES

Figure 1: Cumulative Number of Tested Conditions and Associated Genes for Genetic Testing, 2012-2019
Figure 2: Impact Analysis on the Global Nucleic Acid Isolation and Purification Market
Figure 3: Nucleic Acid Isolation and Purification Market, (by Product), $Million, 2019 vs. 2029
Figure 4: Nucleic Acid Isolation and Purification Consumables Market, (by Type), $Million, 2019 vs. 2029
Figure 5: Nucleic Acid Isolation and Purification Consumables Market, (by Technology), $Million, 2018 vs. 2029
Figure 6: Nucleic Acid Isolation and Purification Consumables Market, (by End User), $Million, 2019 vs. 2029
Figure 7: Global Nucleic Acid Isolation and Purification Consumables Market Snapshot, (by Region)
Figure 8: Nucleic Acid Isolation and Purification Instrument Market, (by Technology), $Million, 2019 vs. 2029
Figure 9: Nucleic Acid Isolation and Purification Instrument Market, (by Throughput), $Million, 2019 vs. 2029
Figure 10: Global Nucleic Acid Isolation and Purification Instrument Market Snapshot, (by Region)
Figure 2.1: Global Nucleic Acid Isolation and Purification Market Segmentation
Figure 3.1: Global Nucleic Acid Isolation and Purification Market Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 3.5: Forecast Methodology
Figure 4.1: North America Nucleic Acid Isolation and Purification Addressable Market, 2019 and 2029
Figure 4.2: EMEA Nucleic Acid Isolation and Purification Addressable Market, 2019-2029
Figure 4.3: Asia-Pacific Nucleic Acid Isolation and Purification Addressable Market, 2019-2029
Figure 4.4: Latin America Nucleic Acid Isolation and Purification Addressable Market, 2019-2029
Figure 5.1: Market Dynamics of Global Nucleic Acid Isolation and Purification Market
Figure 5.2: Key Genetic Disorder Prevalence in the U.S., 2012-2017
Figure 6.1: Share of Key Developments and Strategies
Figure 7.1: Nucleic Acid Isolation and Purification Customer Preference (by Major Brand), N=27
Figure 7.2: Nucleic Acid Isolation and Purification Customer Satisfaction Level (5 Being the Highest) (by Brand) (N=27)
Figure 8.1: Nucleic Acid Isolation and Purification Market (by Product), $Million, 2020 and 2029
Figure 8.2: Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
Figure 8.3: Nucleic Acid Isolation and Purification Kits Market, $Million, 2019-2029
Figure 8.4: Nucleic Acid Isolation and Purification Reagents Market, $Million, 2019-2029
Figure 8.5: Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
Figure 9.1: Nucleic Acid Isolation and Purification Kits Market (by Workflow), $Million, 2020 and 2029
Figure 9.2: Sample Isolation/Extraction/Purification Kits Market, $Million, 2019-2029
Figure 9.3: DNA/RNA Clean-Up and concentration Kits Market, $Million, 2019-2029
Figure 9.4: DNA and RNA Quantification Kits Market, $Million, 2019-2029
Figure 9.5: Nucleic Acid Isolation and Purification Kits Market (by Analyte), $Million, 2020 and 2029
Figure 9.6: DNA Kits Market, $Million, 2019-2029
Figure 9.7: Market Share for DNA Kits Market, $Million, 2018
Figure 9.8: RNA Kits Market, $Million, 2019-2029
Figure 9.9: Market Share for RNA Kits Market, $Million, 2018
Figure 10.1: DNA Isolation and Purification Kits Market (by Source Type), $Million, 2020 and 2029
Figure 10.2: Cell-Free DNA Isolation and Purification Kits Market, $Million, 2019-2029
Figure 10.3: Market Share for Cell-Free DNA Isolation and Purification Kits Market, $Million, 2018
Figure 10.4: Cell-Free DNA Isolation and Purification Kits Market for Blood, $Million, 2019-2029
Figure 10.5: Cell-Free DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2019-2029
Figure 10.6: Cell-Free DNA Isolation and Purification Kits Market for Other Sources, $Million, 2019-2029
Figure 10.7: Cell-Free DNA Isolation and Purification Kits Market for Prenatal and Hereditary Testing, $Million, 2019-2029
Figure 10.8: Cell-Free DNA Isolation and Purification Kits Market for Tumor Testing, $Million, 2019-2029
Figure 10.9: Cell-Free DNA Isolation and Purification Kits Market for Transplantation, $Million, 2019-2029
Figure 10.10: Genomic DNA Isolation and Purification Kits Market, $Million, 2019-2029
Figure 10.11: Market Share for Genomic DNA Isolation and Purification Kits Market, $Million, 2018
Figure 10.12: Genomic DNA Isolation and Purification Kits Market for Blood, $Million, 2019-2029
Figure 10.13: Market Share for Genomic DNA Isolation and Purification Market for Blood, $Million, 2018
Figure 10.14: Genomic DNA Isolation and Purification Kits Market for Body Fluids, $Million, 2019-2029
Figure 10.15: Market Share for Genomic DNA Isolation and Purification Kits Market for Body Fluids, $Million, (2018)
Figure 10.16: Genomic DNA Isolation and Purification Kits Market for Buccal, $Million, 2019-2029
Figure 10.17: Market Share for Genomic DNA Isolation and Purification Kits Market for Buccal, $Million, 2018
Figure 10.18: Genomic DNA Isolation and Purification Kits Market for Cell/Cultured Cell, $Million, 2019-2029
Figure 10.19: Market Share for Genomic DNA Isolation and Purification Kits Market for Cell/Cultured Cell, $Million, 2018
Figure 10.20: Genomic DNA Isolation and Purification Kits Market for FFPE, $Million, 2019-2029
Figure 10.21: Market Share for Genomic DNA Isolation and Purification Kits Market for FFPE, $Million, 2018
Figure 10.22: Genomic DNA Isolation and Purification Kits Market for Forensic, $Million, 2019-2029
Figure 10.23: Market Share for Genomic DNA Isolation and Purification Kits Market for Forensic, $Million, 2018
Figure 10.24: Genomic DNA Isolation and Purification Kits Market for Plant, $Million, 2019-2029
Figure 10.25: Market Share for Genomic DNA Isolation and Purification Kits Market for Plant, $Million, 2018
Figure 10.26: Genomic DNA Isolation and Purification Kits Market for Saliva/Swab, $Million, 2019-2029
Figure 10.27: Market Share for Genomic DNA Isolation and Purification Kits Market for Saliva/Swab, $Million, 2018
Figure 10.28: Genomic DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2019-2029
Figure 10.29: Market Share for Genomic DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2018
Figure 10.30: Genomic DNA Isolation and Purification Kits Market for Tissue, $Million, 2019-2029
Figure 10.31: Market Share for Genomic DNA Isolation and Purification Kits Market for Tissue, $Million, 2018
Figure 10.32: Genomic DNA Isolation and Purification Kits Market for Combined Segment, $Million, 2019-2029
Figure 10.33: Market Share for Genomic DNA Isolation and Purification Kits Market for Combined Segment, $Million, 2018
Figure 10.34: Microbe DNA Isolation and Purification Kits Market, $Million, 2019-2029
Figure 10.35: Market Share for Microbe DNA Isolation and Purification Kits Market, $Million, 2018
Figure 10.36: Microbial DNA Isolation and Purification Kits Market for Bacterial, $Million, 2019-2029
Figure 10.37: Market Share for Microbial DNA Isolation and Purification Kits Market for Bacterial, $Million, 2018
Figure 10.38: Microbial DNA Isolation and Purification Kits Market for Fungus, $Million, 2019-2029
Figure 10.39: Market Share for Microbial DNA Isolation and Purification Kits Market for Fungus, $Million, 2018
Figure 10.40: Microbial DNA Isolation and Purification Kits Market for Yeast, $Million, 2019-2029
Figure 10.41: Market Share for Microbial DNA Isolation and Purification Kits Market for Yeast, $Million, 2018
Figure 10.42: Microbial DNA Isolation and Purification Kits Market for Other Sources, $Million, 2019-2029
Figure 10.43: Plasmid DNA Isolation and Purification Kits Market, $Million, 2019-2029
Figure 10.44: Market Share for Plasmid DNA Isolation and Purification Kits Market, $Million, 2018
Figure 10.45: Plasmid GigaPrep Isolation and Purification Kits Market, $Million, 2019-2029
Figure 10.46: Market Share for Plasmid GigaPrep Isolation and Purification Kits Market, $Million, 2018
Figure 10.47: Plasmid MaxiPrep Isolation and Purification Kits Market, $Million, 2019-2029
Figure 10.48: Market Share for Plasmid MaxiPrep Isolation and Purification Kits Market, $Million, 2018
Figure 10.49: Plasmid MegaPrep Isolation and Purification Kits Market, $Million, 2019-2029
Figure 10.50: Market Share for Plasmid MegaPrep Isolation and Purification Kits Market, $Million, 2018
Figure 10.51: Plasmid MidiPrep Isolation and Purification Kits Market, $Million, 2019-2029
Figure 10.52: Market Share for Plasmid MidiPrep Isolation and Purification Kits Market, $Million, 2018
Figure 10.53: Plasmid MiniPrep Isolation and Purification Kits Market, $Million, 2019-2029
Figure 10.54: Market Share for Plasmid MiniPrep Isolation and Purification Kits Market, $Million, 2018
Figure 10.55: Viral DNA Isolation and Purification Kits Market, $Million, 2019-2029
Figure 10.56: Market Share for Viral DNA Isolation and Purification Kits Market, $Million, 2018
Figure 11.1: RNA Isolation and Purification Kits Market, $Million, 2020 and 2029
Figure 11.2: Genomic RNA Kits Market, $Million, 2019-2029
Figure 11.3: Genomic RNA Kits Market Share, 2018
Figure 11.4: Genomic RNA Kits for Blood Market, $Million, 2019-2029
Figure 11.5: Genomic RNA Extraction Kits from Blood, Market Share, 2018
Figure 11.6: Body Fluids Genomic RNA Kits Market, $Million, 2019-2029
Figure 11.7: Cell/Cultured Cell Genomic RNA Kits Market, $Million, 2019-2029
Figure 11.8: Cell/Cultured Cell Genomic RNA Extraction Kits, Market Share, 2018
Figure 11.9: FFPE Genomic RNA Kits Market, $Million, 2019-2029
Figure 11.10: FFPE Genomic RNA Extraction Kits, Market Share, 2018
Figure 11.11: Plant Genomic RNA Kits Market, $Million, 2019-2029
Figure 11.12: Plant Genomic RNA Extraction Kits, Market Share, 2018
Figure 11.13: Saliva/Swab Genomic RNA Kits Market, $Million, 2019-2029
Figure 11.14: Serum/Plasma Genomic RNA Kits Market, $Million, 2019-2029
Figure 11.15: Serum/Plasma Genomic RNA Extraction Kits, Market Share, 2018
Figure 11.16: Tissue Genomic RNA Kits Market, $Million, 2019-2029
Figure 11.17: Tissue Genomic RNA Extraction Kits, Market Share, 2018
Figure 11.18: Urine Genomic RNA Kits Market, $Million, 2019-2029
Figure 11.19: Other Genomic RNA Kits Market, $Million, 2019-2029
Figure 11.20: Microbial RNA Kits Market, $Million, 2019-2029
Figure 11.21: Microbial RNA Kits Market Share, 2018
Figure 11.22: Bacterial RNA Kits Market, $Million, 2019-2029
Figure 11.23: Bacterial RNA Kits Market Share, 2018
Figure 11.24: Yeast RNA Kits Market, $Million, 2019-2029
Figure 11.25: Yeast RNA Kits Market Share, 2018
Figure 11.26: Fungus RNA Kits Market, $Million, 2019-2029
Figure 11.27: Fungal RNA Kits Market Share, 2018
Figure 11.28: Other Microbial RNA Kits Market, $Million, 2019-2029
Figure 11.29: Viral RNA Kits Market, $Million, 2019-2029
Figure 11.30: Viral RNA Kits Market Share, 2018
Figure 11.31: Cell-Free RNA Kits Market, $Million, 2019-2029
Figure 11.32: cell-free RNA Kits Market Share, 2018
Figure 11.33: Serum/Plasma Cell-Free RNA Kits Market, $Million, 2019-2029
Figure 11.34: Other Cell-Free RNA Kits Market, $Million, 2019-2029
Figure 12.1: Nucleic Acid Isolation and Purification Consumables Market (by Technology), $Million, 2020 and 2029
Figure 12.2: Silica-Based Consumables Market, $Million, 2019-2029
Figure 12.3: Magnetic Particle-based Consumables Market, $Million, 2019-2029
Figure 13.1: Nucleic Acid Isolation and Purification Consumables Market (by Technological Downstream Applications), $Million, 2020 and 2029
Figure 13.2: PCR Market, $Million, 2019-2029
Figure 13.3: qPCR Market, $Million, 2019-2029
Figure 13.4: NGS Market, $Million, 2019-2029
Figure 13.5: Cloning Market, $Million, 2019-2029
Figure 13.6: Microarray Market, $Million, 2019-2029
Figure 13.7: Blotting Techniques Market, $Million, 2019-2029
Figure 13.8: Other Applications Market, $Million, 2019-2029
Figure 14.1: Nucleic Acid Isolation and Purification Consumables Market (by End User), $Million, 2020 and 2029
Figure 14.2: Academic Research Institutes and Laboratories Market, $Million, 2019-2029
Figure 14.3: Pharmaceutical and Biotechnology Companies Market, $Million, 2019-2029
Figure 14.4: Contract Research Organizations Market, $Million, 2019-2029
Figure 14.5: Applied Testing Market, $Million, 2019-2029
Figure 14.6: Clinical Diagnostic Center Market, $Million, 2019-2029
Figure 15.1: Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2020 and 2029
Figure 15.2: North America Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
Figure 15.3: U.S. Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
Figure 15.4: Canada Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
Figure 15.5: EMEA Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
Figure 15.6: LATAM Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
Figure 15.7: APAC Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
Figure 15.8: China Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
Figure 15.9: Japan Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
Figure 15.10: Rest-of-APAC Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
Figure 16.1: Nucleic Acid Isolation and Purification Instrument Market (by Workflow), $Million, 2019 and 2029
Figure 16.2: Isolation/Extraction/Purification Instrument Market, $Million, 2019-2029
Figure 16.3: Quality Control/Quantification Instrument Market, $Million, 2019-2029
Figure 16.4: Nucleic Acid Isolation and Purification Instrument Market (by Technology), $Million, 2019 and 2029
Figure 16.5: Automated Spin Column-Based Instrument Market, $Million, 2019-2029
Figure 16.6: Magnetic Bead-based Instrument Market, $Million, 2019-2029
Figure 16.7: Automated Liquid Handling Instruments Market, $Million, 2019-2029
Figure 16.8: Nucleic Acid Isolation and Purification Instrument Market (by Throughput), $Million, 2019 and 2029
Figure 16.9: Low Throughput Instrument Market, $Million, 2019-2029
Figure 16.10: Medium Throughput Instrument Market, $Million, 2019-2029
Figure 16.11: High Throughput Instrument Market, $Million, 2019-2029
Figure 16.12: Quality Control/Quantification Instruments, (by Technology), $Million, 2019 and 2029
Figure 16.13: Spectrophotometers Market, $Million, 2019-2029
Figure 16.14: Fluorometers Market, $Million, 2019-2029
Figure 16.15: Others Market, $Million, 2019-2029
Figure 16.16: Nucleic Acid Isolation and Purification Instrument Market (by End User), $Million, 2019 and 2029
Figure 16.17: Nucleic Acid Isolation and Purification Instrument Market for Academic Research Institutes, $Million, 2019-2029
Figure 16.18: Nucleic Acid Isolation and Purification Instrument Market for Pharmaceutical and Biotechnology Companies, $Million, 2019-2029
Figure 16.19: Nucleic Acid Isolation and Purification Instrument Market for Clinical Diagnostic Centers, $Million, 2019-2029
Figure 16.20: Nucleic Acid Isolation and Purification Instrument Market for Applied Testing, $Million, 2019-2029
Figure 16.21: Nucleic Acid Isolation and Purification Instrument Market for Contract Research Organizations, $Million, 2019-2029
Figure 16.22: Nucleic Acid Isolation and Purification Instrument Market (by Region), $Million, 2019 and 2029
Figure 16.23: North America Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
Figure 16.24: North America Nucleic Acid Isolation and Purification Instrument Market (by Country), $Million, 2019-2029
Figure 16.25: U.S. Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
Figure 16.26: Canada Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
Figure 16.27: EMEA Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
Figure 16.28: APAC Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
Figure 16.29: APAC Nucleic Acid Isolation and Purification Instrument Market (by Country) $Million, 2019-2029
Figure 16.30: China Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
Figure 16.31: Japan Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
Figure 16.32: Rest-of-APAC Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
Figure 16.33: LATAM Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
Figure 17.1: Market Share Analysis for the Global Nucleic Acid Isolation and Purification Instrument Market, 2018
Figure 17.2: Global Nucleic Acid Isolation and Purification Kits Market Share, 2018
Figure 17.3: Market Share Analysis for the North America Nucleic Acid Isolation and Purification Instrument Market, 2018
Figure 17.4: Market Share Analysis for the North America Nucleic Acid Isolation and Purification Kits Market, 2018
Figure 17.5: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification Instrument Market, 2018
Figure 17.6: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification Kits Market, 2018
Figure 17.7: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by End User)
Figure 17.8: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by Region)
Figure 17.9: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by Product)
Figure 18.1: Business Expansion Opportunity Mapping (by Product)
Figure 18.2: Business Expansion Opportunity Mapping (by Region)
Figure 18.3: Nucleic Acid Isolation and Purification Market: SWOT Analysis
Figure 19.1: Total Number of Companies Profiles
Figure 19.2: Agilent Technologies, Inc.: Key Product Portfolio
Figure 19.3: Agilent Technologies, Inc.: Overall Financials, 2017-2019
Figure 19.4: Agilent Technologies, Inc.: Revenue (by Segment), 2017-2019
Figure 19.5: Agilent Technologies, Inc.: Revenue (by Region), 2017-2019
Figure 19.6: Agilent Technologies, Inc.: R&D Expenditure, 2017-2019
Figure 19.7: Agilent Technologies, Inc.: SWOT Analysis
Figure 19.8: Analytik Jena AG: Key Product Portfolio
Figure 19.9: Analytik Jena AG: SWOT Analysis
Figure 19.10: Bio-Rad Laboratories, Inc.: Key Product Portfolio
Figure 19.11: Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
Figure 19.12: Bio-Rad Laboratories, Inc.: Sales (by Segment), $Million, 2016-2018
Figure 19.13: Bio-Rad Laboratories, Inc.: Sales (by Region), 2016-2018
Figure 19.14: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2016-2018
Figure 19.15: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 19.16: Exact Sciences Corporation: Key Product Portfolio
Figure 19.17: Exact Sciences Corporation: Overall Financials, 2017-2019
Figure 19.18: Exact Sciences Corporation: Revenue (by Region), 2017-2019
Figure 19.19: Exact Sciences Corporation: R&D Expenditure, 2017-2019
Figure 19.20: Exact Sciences Corporation: SWOT Analysis
Figure 19.21: F. Hoffmann-La Roche AG: Key Product Portfolio
Figure 19.22: F. Hoffmann-La Roche AG: Overall Financials, 2016-2018
Figure 19.23: F. Hoffmann-La Roche AG: Revenue (by Segment), $Million, 2016-2018
Figure 19.24: F. Hoffmann-La Roche AG: Revenue (by Region), 2016-2018
Figure 19.25: F. Hoffmann-La Roche AG: R&D Expenditure, 2016-2018
Figure 19.26: F. Hoffmann-La Roche AG: SWOT Analysis
Figure 19.27: GE: Key Product Portfolio
Figure 19.28: General Electric Company: Overall Financials, 2016-2018
Figure 19.29: General Electric Company: Revenue (by Segment), 2016-2018
Figure 19.30: General Electric Company: Revenue Split for Healthcare, 2016-2018
Figure 19.31: General Electric: Healthcare Revenue (by Region), 2016-2018
Figure 19.32: General Electric Company: R&D Expenditure, 2016-2018
Figure 19.33: General Electric Company: SWOT Analysis
Figure 19.34: Illumina, Inc.: Key Product Portfolio
Figure 19.35: Illumina, Inc.: Overall Financials, 2016-2018
Figure 19.36: Illumina, Inc.: Revenue (by Segment), $Million, 2016-2018
Figure 19.37: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 19.38: Illumina, Inc.: R&D Expenditure, 2016-2018
Figure 19.39: Illumina, Inc.: SWOT Analysis
Figure 19.40: Merck KGaA: Key Product Offerings
Figure 19.41: Merck KGaA: Overall Financials, 2016-2018
Figure 19.42: Merck KGaA: Revenue (by Segment), $Million, 2016-2018
Figure 19.43: Merck KGaA: Revenue (by Region), 2016-2018
Figure 19.44: Merck KGaA: R&D Expenditure, 2016-2018
Figure 19.45: Merck KGaA: SWOT Analysis
Figure 19.46: Meridian Bioscience: Key Product Portfolio
Figure 19.47: Meridian Bioscience: Overall Financials, 2017-2019
Figure 19.48: Meridian Bioscience Revenue (by Segment), 2017-2019
Figure 19.49: Meridian Bioscience: Revenue (by Region), 2017-2019
Figure 19.50: Meridian Bioscience: R&D Expenditure, 2017-2019
Figure 19.51: Meridian Bioscience: SWOT Analysis
Figure 19.52: Macherey-Nagel GmbH & Co KG: Key Product Portfolio
Figure 19.53: Macherey-Nagel GmbH & Co KG: SWOT Analysis
Figure 19.54: New England Biolabs, Inc: Key Product Offerings
Figure 19.55: New England Biolabs, Inc.: SWOT Analysis
Figure 19.56: Norgen Biotek Corp.: Key Product Portfolio
Figure 19.57: Norgen Biotek Corp.: SWOT Analysis
Figure 19.58: Omega Bio-Tek: Key Product Portfolio
Figure 19.59: Omega Bio-Tek: SWOT Analysis
Figure 19.60: Orasure Technologies, Inc.: Key Product Portfolio
Figure 19.61: Orasure Technologies, Inc.: Overall Financials, 2016-2018
Figure 19.62: Orasure Technologies, Inc. Revenue (by Segment), 2016-2018
Figure 19.63: Orasure Technologies, Inc.: Revenue (by Region), 2016-2018
Figure 19.64: Orasure Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 19.65: Orasure Technologies, Inc.: SWOT Analysis
Figure 19.66: PerkinElmer, Inc.: Key Product Portfolio
Figure 19.67: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
Figure 19.68: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
Figure 19.69: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
Figure 19.70: PerkinElmer, Inc.: R&D Expenditure, 2016-2018
Figure 19.71: PerkinElmer, Inc.: SWOT Analysis
Figure 19.72: Promega Corporation: Key Product Portfolio
Figure 19.73: Promega Corporation: SWOT Analysis
Figure 19.74: QIAGEN N.V.: Key Product Offerings
Figure 19.75: QIAGEN N.V.: Overall Financials, 2016-2018
Figure 19.76: QIAGEN N.V.: Revenue (by Segment), $Million, 2016-2018
Figure 19.77: QIAGEN N.V.: Revenue (by Region), 2016-2018
Figure 19.78: QIAGEN N.V.: R&D Expenditure, 2016-2018
Figure 19.79: QIAGEN N.V.: SWOT Analysis
Figure 19.80: Sage Science, Inc.: Key Product Portfolio
Figure 19.81: Sage Science, Inc.: SWOT Analysis
Figure 19.82: Tecan Group: Key Product Portfolio
Figure 19.83: Tecan Group: Overall Financials, 2016-2018
Figure 19.84: Tecan Group Revenue (by Segment), 2016-2018
Figure 19.85: Tecan Group: Revenue (by Region), 2016-2018
Figure 19.86: Tecan Group: R&D Expenditure, 2016-2018
Figure 19.87: Tecan Group: SWOT Analysis
Figure 19.88: Thermo Fisher Scientific Inc.: Key product Offerings
Figure 19.89: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 19.90: Thermo Fisher Scientific Inc: Sales (by Segment), $Million, 2016-2018
Figure 19.91: Thermo Fisher Scientific Inc.: Sales (by Region), 2016-2018
Figure 19.92: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 19.93: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 19.94: Zymo Research: Key Product Portfolio
Figure 19.95: Zymo Research: SWOT Analysis


More Publications